Juvenile idiopathic arthritis (JIA) is a chronic, autoimmune, inflammatory joint disease.
It is the most common arthritis in children and adolescents. Pharmaceutical therapy including non-steroidal anti-inflammatory drugs, corticosteroid injections
and biological drugs are the forefront of gold standard care in JIA. Emerging evidence on the non-invasive, physical and mechanical therapies in JIA, suggest
that allied health professionals (AHP) also play an important role as part of this gold standard approach. This paper by local authors, published in the Journal
of paediatrics and child health
, aims to assist AHP in attaining gold standard practice, by providing evidence-based summaries on the presentation
of lower limb pathologies in JIA and the allied health therapies available.